Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Carisoprodol | HCID 2576 | — |
| Reactant | Diclofenac sodium | HCID 5018304 | — |
| Product | HCID 86761421 | HCID 86761421 | — |
Reaction Steps
A second composition to cover the perforated coated cores is prepared as follows: carisoprodol, diclofenac sodium, a diluent and a hinder are placed in a high shear mixer and mix for 5 minutes. The granulation process is initiated by the gradual addition of a granulating solution containing a plasticizer and purified water to the high shear with continuous blending to produce a wet blend. Next, the wet blend is granulated and dried at 40-500 for 20 minutes in a fluid bed to remove the water. Then, the dry granules are screened through a 20 USP mesh screen for size reduction. Next, the screened granules are mixed with a glidant and a lubricant, that have been previously passed through a 60 mesh screen, in a V-Blender during 5 minutes. The granulate is applied over the perforated cores through compression to obtain carisoprodol-diclofenac coated osmotic devices. The coated device has an outer diameter of about 14 mm.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08029822B2 |
|---|
| Source dataset | uspto-grants-2011_10 |
|---|
| ORD ID | ord-89c5569bfeb34ed09ec983411c004cca |
|---|
| Source note | uspto-grants-2011_10 |
|---|